Patents by Inventor Michel Varrin-Doyer

Michel Varrin-Doyer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20160075748
    Abstract: The present disclosure provides human Aquaporin 4 (AQP4) peptides and peptides having homology to human Aquaporin 4 (AQP4) peptides. Also provided herein are methods for using human AQP4 peptides and peptides homologous to human AQP4 peptides for diagnosing and/or treating Neuromyelitis Optica.
    Type: Application
    Filed: September 11, 2015
    Publication date: March 17, 2016
    Inventors: SCOTT S. ZAMVIL, Michel Varrin-Doyer, Bruce Anthony Campbell Cree
  • Patent number: 9234017
    Abstract: The present disclosure provides human Aquaporin 4 (AQP4) peptides and peptides having homology to human Aquaporin 4 (AQP4) peptides. Also provided herein are methods for using human AQP4 peptides and peptides homologous to human AQP4 peptides for diagnosing and/or treating Neuromyelitis Optica.
    Type: Grant
    Filed: December 10, 2013
    Date of Patent: January 12, 2016
    Assignee: The Regents of the University of California
    Inventors: Scott S. Zamvil, Michel Varrin-Doyer, Bruce Anthony Campbell Cree
  • Publication number: 20140199333
    Abstract: The present disclosure provides human Aquaporin 4 (AQP4) peptides and peptides having homology to human Aquaporin 4 (AQP4) peptides. Also provided herein are methods for using human AQP4 peptides and peptides homologous to human AQP4 peptides for diagnosing and/or treating Neuromyelitis Optica.
    Type: Application
    Filed: December 10, 2013
    Publication date: July 17, 2014
    Applicant: The Regents of the University of California
    Inventors: Scott S. Zamvil, Michel Varrin-Doyer, Bruce Anthony Campbell Cree